Glenmark Pharmaceuticals has received the USFDA’s final approval for generic Triamcinolone Acetonide ointment which is used in treating skin inflammation.

The company has said in a statement that Glenmark Pharmaceuticals Inc USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Triamcinolone Acetonide ointment USP, 0.1 percent.

It added that the product is a generic version of Mylan Pharmaceuticals Inc’s Kenalog ointment in the same strength.

Read EquityPandit’s Technical Analysis on Nifty Pharma